Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

NCT04998669

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Florida Cancer Specialists and Research Institute Fort Myers, Florida, United States
  • University of Miami Miami, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

NCT04830137

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +36 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver, Colorado, United States
View all 16 locations
View Trial Details
Recruiting

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT06153251

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 19 locations
View Trial Details
Recruiting

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

NCT03590171

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Australian & New Zealand Childhood Hematology & Oncology Group Clayton, Victoria, Australia
  • St. Anna Kinderkrebsforschung, CCRI Vienna, Austria
  • Hòpital Universitaire des Enfants Reine Fabiola Brussels, Belgium
  • University Hospital Motol Prague, Czechia
View all 15 locations
View Trial Details

Related conditions